Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Non-Alcoholic Steatohepatitis (NASH) is a severe form of Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) characterized by hepatic steatosis, liver inflammation, fibrosis and damage due to fat accumulation. It occurs in around 20-30% of NAFLD patients.
Ajmera & Loomba …